The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
Open accessAbstract
To clarify the relationship between hepatitis C virus infection and the development of hepatocellular carcinoma as sequelae of non-A, non-B posttransfusion hepatitis, 231 patients with chronic non-A, non-B hepatitis (96 with chronic hepatitis, 81 with cirrhosis and 54 with hepatocellular carcinoma) were analyzed for antibody to hepatitis C virus and were compared with 125 patients with chronic hepatitis B (50 with chronic hepatitis, 46 with cirrhosis and 29 with hepatocellular carcinoma). Antibody to hepatitis C virus was detected in 89.6%, 86.4% and 94.4% of patients with non-A, non-B hepatitis-related chronic hepatitis, cirrhosis and hepatocellular carcinoma, respectively, compared with 6%, 17.4% and 34.5% with similar diseases related to hepatitis B. A history of transfusion was documented in 52%, 33% and 42% of anti-hepatitis C virus-positive cases of chronic hepatitis, cirrhosis and hepatocellular carcinoma. The mean intervals between the date of transfusion and the date of diagnosis of anti-hepatitis C virus—positive chronic hepatitis, cirrhosis and hepatocellular carcinoma were 10, 21.2 and 29 yr, respectively. In 21 patients with transfusion-associated hepatocellular carcinoma, anti-hepatitis C virus was present in each serial sample available for testing, including samples obtained up to 14 yr before the diagnosis of hepatocellular carcinoma. These data suggest the slow, sequential progression from acute hepatitis C virus—related non-A, non-B hepatitis through chronic hepatitis and cirrhosis to hepatocellular carcinoma and support a causal association between hepatitis C virus and hepatocellular carcinoma. (HEPATOLOGY 1990; 12:671-675).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
Kuo, G., Choo, Q.-L., Alter, H. J., Gitnick, G. L., Redeker, A. G., Purcell, R. H., Miyamura, T., Dienstag, J. L., Alter, M. J., Stevens, C. E., et al. (1989) · Science · doi:10.1126/science.2496467 · Cited by 3,346
Self-citationHEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
Esteban, J. I., Viladomiu, L., Gonzalez, A., Roget, M., Genescà, J., Esteban, R., López-Talavera, J. C., Hernández, J. M., Vargas, V., Buti, M., et al. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90485-6 · Cited by 886
Bruix, J., Calvet, X., Costa, J., Ventura, M., Bruguera, M., Castillo, R., María Barrera, J., Ercilla, G., María Sanchez-Tapias, J., Vall, M., et al. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91015-5 · Cited by 734
Shafritz, D. A., Shouval, D., Sherman, H. I., Hadziyannis, S. J., & Kew, M. C. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110293051807 · Cited by 711
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Colombo, M., Choo, Q. L., Del Ninno, E., Dioguardi, N., Kuo, G., Donato, M. F., Tommasini, M. A., & Houghton, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91016-7 · Cited by 666
Viral Hepatitis and Liver Disease
Gupta, S., & Ott, M. (1998) · Principles of Molecular Medicine · doi:10.1007/978-1-59259-726-0_43 · Cited by 518
Hemagglutination Assay for Antigen and Antibody Associated with Viral Hepatitis
Vyas, G. N., & Shulman, N. R. (1970) · Science · doi:10.1126/science.170.3955.332 · Cited by 479
TREATMENT OF ALCOHOLISM WITH A SENSITISING DRUG
Martensen-Larsen, O. (1948) · The Lancet · doi:10.1016/s0140-6736(48)91515-3 · Cited by 442
Importance of Heterosexual Activity in the Transmission of Hepatitis B and Non-A, Non-B Hepatitis
Alter, M. J. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430090063034 · Cited by 435
Cited by
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754
Natural history of chronic hepatitis C
Seeff, L. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36806 · Cited by 1,424
Evolving epidemiology of hepatitis C virus
Lavanchy, D. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03432.x · Cited by 1,318
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Ogura, Y., Izumi, N., Marumo, F., & Sato, C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340203 · Cited by 998
Nishiguchi, S., Kuroki, T., Nakatani, S., Morimoto, H., Takeda, T., Nakajima, S., Shiomi, S., Seki, S., Kobayashi, K., & Otani, S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91739-x · Cited by 857
Thein, H., Yi, Q., Dore, G. J., & Krahn, M. D. (2008) · Hepatology · doi:10.1002/hep.22375 · Cited by 829
Alter, H. J., & Seeff, L. B. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9505 · Cited by 736
Self-citationHepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
Gomaa, A. I., Khan, S. A., Toledano, M. B., Waked, I., & Taylor-Robinson, S. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4300 · Cited by 700
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell-Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 672
Self-citationMuto, Y., Moriwaki, H., Ninomiya, M., Adachi, S., Saito, A., Takasaki, K. T., Tanaka, T., Tsurumi, K., Okuno, M., Tomita, E., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606133342402 · Cited by 668
Estimating progression to cirrhosis in chronic hepatitis C virus infection
Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., Marinos, G., & Kaldor, J. M. (2001) · Hepatology · doi:10.1053/jhep.2001.27831 · Cited by 620
The Long–Term Pathological Evolution of Chronic Hepatitis C
Yano, M., Kumada, H., Kage, M., Ikeda, K., Shimamatsu, K., Inoue, O., Hashimoto, E., Lefkowitch, J. H., Ludwig, J., & Okuda, K. (1996) · Hepatology · doi:10.1002/hep.510230607 · Cited by 598
Hepatitis C and hepatocellular carcinoma
Di Bisceglie, A. M. (1997) · Hepatology · doi:10.1002/hep.510260706 · Cited by 558
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 539
Self-citationTransmission of disease through transplantation of musculoskeletal allografts.
Tomford, W. W. (1995) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199511000-00017 · Cited by 474
Lerat, H., Honda, M., Beard, M. R., Loesch, K., Sun, J., Yang, Y., Okuda, M., Gosert, R., Xiao, S., Weinman, S. A., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.31001 · Cited by 473
Kasahara, A., Hayashi, N., Mochizuki, K., Takayanagi, M., Yoshioka, K., Kakumu, S., Iijima, A., Urushihara, A., Kiyosawa, K., Okuda, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270529 · Cited by 467
Self-citationOkuda, K. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80428-6 · Cited by 443
Natural history of hepatitis C
Seeff, L. B. (1997) · Hepatology · doi:10.1002/hep.510260704 · Cited by 409
Hepatitis C in the HIV-Infected Person
Sulkowski, M. S., & Thomas, D. L. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00012 · Cited by 405
The long term efficacy of glycyrrhizin in chronic hepatitis C patients
Arase, Y., Ikeda, K., Murashima, N., Chayama, K., Tsubota, A., Koida, I., Suzuki, Y., Saitoh, S., Kobayashi, M., & Kumada, H. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970415)79:8<1494::aid-cncr8>3.0.co;2-b · Cited by 403
Natural History of Hepatitis C
Thomas, D. L., & Seeff, L. B. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2005.05.003 · Cited by 402
Honda, M., Sakai, A., Yamashita, T., Nakamoto, Y., Mizukoshi, E., Sakai, Y., Yamashita, T., Nakamura, M., Shirasaki, T., Horimoto, K., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.049 · Cited by 400
American Gastroenterological Association Technical Review on the Management of Hepatitis C
Dienstag, J. L., & McHutchison, J. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.010 · Cited by 384
Global epidemiology and burden of HCV infection and HCV-related disease
Thrift, A. P., El-Serag, H. B., & Kanwal, F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.176 · Cited by 382
Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy
Hagiwara, H., Hayashi, N., Mita, E., Takehara, T., Kasahara, A., Fusamoto, H., & Kamada, T. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)91025-d · Cited by 377
Ura, S., Honda, M., Yamashita, T., Ueda, T., Takatori, H., Nishino, R., Sunakozaka, H., Sakai, Y., Horimoto, K., & Kaneko, S. (2009) · Hepatology · doi:10.1002/hep.22749 · Cited by 376
Genetic Epidemiology of Hepatitis C Virus throughout Egypt
Ray, S. C., Arthur, R. R., Carella, A., Bukh, J., & Thomas, D. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315786 · Cited by 375
Epidemiology and natural history of hepatocellular carcinoma
McGlynn, K. A., & London, W. T. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.10.004 · Cited by 373
Hepatitis C virus infection in dialysis and renal transplantation
Pereira, B. J. G., & Levey, A. S. (1997) · Kidney International · doi:10.1038/ki.1997.139 · Cited by 373
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death
Degos, F., Christidis, C., Ganne-Carrie, N., Farmachidi, J.-P., Degott, C., Guettier, C., Trinchet, J.-C., Beaugrand, M., & Chevret, S. (2000) · Gut · doi:10.1136/gut.47.1.131 · Cited by 370
Lefkowitch, J. H., Schiff, E. R., Davis, G. L., Perrillo, R. P., Lindsay, K., Bodenheimer, H. C., Balart, L. A., Ortego, T. J., Payne, J., Dienstag, J. L., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90432-c · Cited by 368
Shiratori, Y., Shiina, S., Imamura, M., Kato, N., Kanai, F., Okudaira, T., Teratani, T., Tohgo, G., Toda, N., Ohashi, M., et al. (1995) · Hepatology · doi:10.1002/hep.1840220403 · Cited by 365
Correlates of Hepatitis C Virus Infections among Injection Drug Users
Thomas, D. L., Vlahov, D., Solomon, L., Cohn, S., Taylor, E., Garfein, R., & Nelson, K. E. (1995) · Medicine · doi:10.1097/00005792-199507000-00005 · Cited by 362
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy†
Everson, G. T., Trotter, J., Forman, L., Kugelmas, M., Halprin, A., Fey, B., & Ray, C. (2005) · Hepatology · doi:10.1002/hep.20793 · Cited by 357
Kanto, T., Hayashi, N., Takehara, T., Tatsumi, T., Kuzushita, N., Ito, A., Sasaki, Y., Kasahara, A., & Hori, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5584 · Cited by 356
Wiese, M., Berr, F., Lafrenz, M., Porst, H., & Oesen, U. (2000) · Hepatology · doi:10.1053/jhep.2000.8169 · Cited by 349
45-Year Follow-up of Hepatitis C Virus Infection in Healthy Young Adults
Seeff, L. B., Miller, R. N., Rabkin, C. S., Buskell-Bales, Z., Straley-Eason, K. D., Smoak, B. L., Johnson, L. D., Lee, S. R., & Kaplan, E. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00003 · Cited by 347
Fattovich, G. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05474-6 · Cited by 333
Tanaka, Y., Hanada, K., Mizokami, M., Yeo, A. E. T., Shih, J. W.-K., Gojobori, T., & Alter, H. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242608099 · Cited by 331
Self-citationTHE EPIDEMIOLOGY OF VIRAL HEPATITIS IN THE UNITED STATES
Alter, M. J., & Mast, E. E. (1994) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00146-1 · Cited by 324
Seeff, L. B., Hollinger, B. F., Alter, H. J., Wright, E. C., Cain, C. M. B., Buskell, Z. J., Ishak, K. G., Iber, F. L., Toro, D., Samanta, A., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.21905 · Cited by 321
Self-citationMedical therapies for hepatocellular carcinoma: a critical view of the evidence
Villanueva, A., Hernandez-Gea, V., & Llovet, J. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.199 · Cited by 314
Epidemiology, Risk Factors, and Natural History of Hepatocellular Carcinoma
MONTALTO, G., CERVELLO, M., GIANNITRAPANI, L., DANTONA, F., TERRANOVA, A., & CASTAGNETTA, L. A. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04090.x · Cited by 312
Hepatocellular carcinoma: Recent trends in Japan
Kiyosawa, K., Umemura, T., Ichijo, T., Matsumoto, A., Yoshizawa, K., Gad, A., & Tanaka, E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.012 · Cited by 308
Self-citationTransmission of the hepatitis-C virus by tissue transplantation.
Conrad, E. U., Gretch, D. R., Obermeyer, K. R., Moogk, M. S., Sayers, M., Wilson, J. J., & Strong, D. M. (1995) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199502000-00007 · Cited by 305
Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C
Radkowski, M., Gallegos-Orozco, J. F., Jablonska, J., Colby, T. V., Walewska-Zielecka, B., Kubicka, J., Wilkinson, J., Adair, D., Rakela, J., & Laskus, T. (2005) · Hepatology · doi:10.1002/hep.20518 · Cited by 304
Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection†
Asahina, Y., Tsuchiya, K., Tamaki, N., Hirayama, I., Tanaka, T., Sato, M., Yasui, Y., Hosokawa, T., Ueda, K., Kuzuya, T., et al. (2010) · Hepatology · doi:10.1002/hep.23691 · Cited by 291
Prospective study of chemoprevention of hepatocellular carcinoma with sho-saiko-to (TJ-9)
Oka, H., Yamamoto, S., Kuroki, T., Harihara, S., Marumo, T., Kim, S. R., Monna, T., Kobayashi, K., & Tango, T. (1995) · Cancer · doi:10.1002/1097-0142(19950901)76:5<743::aid-cncr2820760506>3.0.co;2-v · Cited by 269
Natural history of hepatitis C: Its impact on clinical management
Di Bisceglie, A. M. (2000) · Hepatology · doi:10.1053/he.2000.5762 · Cited by 263
Fabrizi, F., Martin, P., Dixit, V., Bunnapradistd, S., & Dulai, G. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00864.x · Cited by 260
Silini, E., Bono, F., Cividini, A., Cerino, A., Bruno, S., Rossi, S., Belloni, G., Brugnetti, B., Civardi, E., Salvaneschi, L., et al. (1995) · Hepatology · doi:10.1002/hep.1840210204 · Cited by 252
Hoo, L. S., Zhang, J. Y., & Chan, E. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205625 · Cited by 201
“Acute and chronic liver diseases such as an unremitting infection with HBV or HCV followed by cirrhosis places patients at increased risk of developing HCC (Kiyosawa et al., 1990).”
BackgroundGoodgame, B., Shaheen, N. J., Galanko, J., & El-Serag, H. B. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07678.x · Cited by 72
Tanaka, H., Tsukuma, H., Yamano, H., Oshima, A., & Shibata, H. (2004) · International Journal of Cancer · doi:10.1002/ijc.20507 · Cited by 57
Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats
Oyama, K. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.885 · Cited by 50
Viral hijacking of host caspases: an emerging category of pathogen–host interactions
Connolly, P. F., & Fearnhead, H. O. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.59 · Cited by 44
Cividini, A., Pistorio, A., Regazzetti, A., Cerino, A., Tinelli, C., Mancuso, A., Ribola, M., Galli, M. L., Agnusdei, A., Leone, M., et al. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80348-0 · Cited by 35
Tsega, E., Nordenfeit, E., & Hansson, B. G. (1995) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(95)90482-4 · Cited by 33
Metadata
- Authors
- Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R. H., & Alter, H. J.
- Venue
- Hepatology
- Published
- 1990-10
- Volume
- 12
- Issue
- 4
- Pages
- 671-675
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2088053309
- Cited by
- 1,217
- References
- 15
- FWCI
- 24.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.